Predictions
WAVE Life Sciences Ltd
Start price
Target price
Perf. (%)
€6.45
29.10.20
29.10.20
-
04.11.21
04.11.21
-0.78%
04.11.20
04.11.20
Could be very worthwhile Investment >20% year
Charles Schwab Corp.
Start price
Target price
Perf. (%)
€34.40
29.10.20
29.10.20
-
04.11.21
04.11.21
26.48%
01.01.21
01.01.21
negative Cash Flow expected
Revenue decline/stagnation expected
High valuation
Low dividend yield expected
Xinyi Solar Holdings Ltd
Start price
Target price
Perf. (%)
€1.79
29.10.20
29.10.20
€2.00
04.11.21
04.11.21
-18.99%
11.11.20
11.11.20
Risky Investment
BYD Co. Ltd
Start price
Target price
Perf. (%)
€17.02
29.10.20
29.10.20
€33.00
04.11.21
04.11.21
101.59%
05.11.21
05.11.21
Sustainability is important
Could be worthwhile Investment >10% per year
Capable Management
Good culture
Apple Inc.
Start price
Target price
Perf. (%)
€96.02
29.10.20
29.10.20
€140.00
04.11.21
04.11.21
36.97%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Meta Platforms Inc.
Start price
Target price
Perf. (%)
€236.70
29.10.20
29.10.20
€245.00
30.10.20
30.10.20
-5.13%
30.10.20
30.10.20
Some uniques
Risky Investment
Idexx Laboratories Inc.
Start price
Target price
Perf. (%)
€371.00
29.10.20
29.10.20
-
04.11.21
04.11.21
8.65%
30.12.20
30.12.20
EBIT growth >5% per year expected
Very low/no dividend yield expected
ElringKlinger AG
Start price
Target price
Perf. (%)
€8.53
29.10.20
29.10.20
€10.00
31.10.20
31.10.20
2.81%
31.10.20
31.10.20
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Stable Large shareholder and/or long term investor
Luckin Coffee Inc.
Start price
Target price
Perf. (%)
€3.78
29.10.20
29.10.20
-
04.11.21
04.11.21
83.60%
10.01.21
10.01.21
High risks in the balance sheet
Deficits in Management
High risks for its business
Risky Investment
Solaredge Technologies Inc
Start price
Target price
Perf. (%)
€225.50
29.10.20
29.10.20
-
04.11.21
04.11.21
34.90%
05.11.21
05.11.21
Revenue growth > 30% per year expected
Capable Management
Market Leader or Top 3
Cocrystal Pharma Inc.
Start price
Target price
Perf. (%)
€8.64
28.10.20
28.10.20
-
04.11.21
04.11.21
31.94%
15.07.21
15.07.21
Could be very worthwhile Investment >20% year
Horizon Pharma plc
Start price
Target price
Perf. (%)
€65.91
28.10.20
28.10.20
-
04.11.21
04.11.21
-7.22%
13.11.20
13.11.20
Could be very worthwhile Investment >20% year
Aytu Biopharma Inc.
Start price
Target price
Perf. (%)
€160.00
28.10.20
28.10.20
-
04.11.21
04.11.21
-54.25%
15.07.21
15.07.21
Risky Investment
Outdated or very high risk business model
Expedia Inc.
Start price
Target price
Perf. (%)
€79.34
28.10.20
28.10.20
€76.00
04.11.21
04.11.21
6.02%
04.11.20
04.11.20
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
Good rating
Splunk Inc.
Start price
Target price
Perf. (%)
€176.36
28.10.20
28.10.20
€159.00
04.11.21
04.11.21
0.77%
04.11.20
04.11.20
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
International Business Machines Corp
Start price
Target price
Perf. (%)
€90.20
28.10.20
28.10.20
€89.00
04.11.21
04.11.21
9.18%
13.11.20
13.11.20
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Undervalued
Kandi Technologies Corp.
Start price
Target price
Perf. (%)
€5.53
28.10.20
28.10.20
€4.70
02.11.20
02.11.20
4.27%
02.11.20
02.11.20
EBIT growth >5% per year expected
Innovative
Future proof or reliable business model
Sustainability is little important
Schaeffler AG
Start price
Target price
Perf. (%)
€5.10
28.10.20
28.10.20
€4.50
04.11.21
04.11.21
8.82%
04.11.20
04.11.20
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Socket Mobile Inc.
Start price
Target price
Perf. (%)
€3.20
28.10.20
28.10.20
€2.00
31.10.20
31.10.20
-31.88%
31.10.20
31.10.20
Risky Investment
Vonovia SE ADR
Start price
Target price
Perf. (%)
€26.59
28.10.20
28.10.20
-
04.11.21
04.11.21
7.00%
05.01.21
05.01.21
Small cyclical dependencies
Market Leader or Top 3
Higher risks for its business
Alphabet Inc. A
Start price
Target price
Perf. (%)
€67.04
28.10.20
28.10.20
€0.090
04.11.21
04.11.21
91.60%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Kala Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€267.50
27.10.20
27.10.20
€300.00
31.10.20
31.10.20
8.41%
31.10.20
31.10.20
Could be worthwhile Investment >10% per year